
Yale University Introduces Cas12a-Based Method for Dual Gene Activation and Knockout
March 26, 2025 |
Harnessing the power of CRISPR-Cas12a technology, Yale University researchers developed a novel system for dual-gene activation and knockout (DAKO). This new system allows a single treatment to cause two events at the same time- the activation of one gene and the suppression of another.
DAKO uses Cas19a and can be as precise as Cas9, with the additional benefit of performing multiple edits at once. Thus, it is an ideal system to develop a new biological model for testing various hypotheses. With DAKO gene editing, it is now possible to boost both the desired activity beyond normal levels and remove the system that would inhibit this desired effect. DAKO system could revolutionize treatments, especially in oncology, neurology, and metabolic therapies.
Read more from Nature and Securities IO.
|
You might also like:
- Study Finds Cas12a More Effective than Cas9 in Generating Knockout Mutants in MiRNA Genes in Rice
- New Cas12a Enzymes Show Promise for Plant Gene Editing
- Experts Enhance Editing Rates of CRISPR-Cas12a
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
Gene Editing Supplement (March 26, 2025)
-
Research and Tools
- CRISPR-Cas9 Helps Enhance Cassava's Disease Resistance, Drought Tolerance, and Starch Biosynthesis
- Researchers Identify Gene Regulating Grain Weight in Wheat
- OsMADS60 Controls Rice Yield Through Auxin Transport
- Yale University Introduces Cas12a-Based Method for Dual Gene Activation and Knockout
-
Read the latest: - Biotech Updates (April 30, 2025)
- Gene Editing Supplement (April 30, 2025)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet